BARC-IR Repository :: Browsing by Author "Ostwal, V."

Browsing by Author "Ostwal, V."

Now showing 1 - 5 of 5

The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios
(2016) Basu, Sandip; Ostwal, V.
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: Is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
(2016) Basu, Sandip; Ostwal, V.
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics
(2016) Thapa, P.; Ranade, R.; Ostwal, V.; Shrikhande, S. V.; Goel, M.; Basu, Sandip
Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist’s perspective
(2016) Paul, D.; Ostwal, V.; Bose, S.; Basu, Sandip
Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting
(2018) Kalshetty, A.; Ramaswamy, A.; Ostwal, V.; Basu, Sandip